sacituzumab
gilead sciences
['breast', 'sacituzumab', 'mbc', 'tropics-02']
another advance in hr+her2- mbc presented at #esmo2022. in #tropics-02 trial sacituzumab govitecan improved os by 3.2 months vs. tpc as well as improvement in orr and qol in heavily pretreated pts. the evolving era of #adcs in breast cancer continues. 
Medical Oncologist, Breast Cancer Program at Hospital Moinhos de Vento, Clinical Investigator at Hospital São Lucas @PUCRS, Chair @Lacog_group